Abstract

Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together

Author(s): McElhiney Linda F

Issue: Jul/Aug 2010 - Sterile Compounding

Page(s): 270-274

Download in electronic PDF format for $75
  • Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Page 1
  • Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Page 2
  • Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Page 3
  • Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Page 4
  • Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Page 5

Abstract

With the development of new treatment options and reported side effects with the use of silver nitrate ophthalmic solution, the drug manufacturers discontinued production of the silver nitrate ophthalmic solution in the mid 1990s. On December 9, 2009, the U.S. Food and Drug Administration announced that the erythromycin ophthalmic ointment 1-gram tubes were commercially available again and production by the manufacturer was expected to meet the historical demands. Hospitals could expect to replenish their inventory reserves after the first quarter of 2010. However, manufacturer backorders have been increasing due to a variety of factors. If a hospital has a compounding laboratory, it is possible to prepare erythromycin ophthalmic ointment according to the United States Pharmacopeia Chapter <797> standards. Since the commercial product has been available for decades without any major shortages until 2009, there isn’t any published compounding information on how to prepare the ointment. This article discusses t

Related Keywords

  • gonococcal ophthalmia neonatorum
  • neonatal blindness
  • newborns
  • erythromycin ophthalmic ointment
  • prophylaxis
  • drug shortage
  • treatment alternatives
  • topical antibiotic
  • intraocular antimicrobial
  • ocular administration
  • eye infection
  • formulation

Related Categories

  • FORMULATIONS
  • OPHTHALMICS
  • PEDIATRICS
  • STERILE PREPARATIONS
  • DOSAGE FORMS/DRUG CARRIERS
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2010
Pg. 270-274
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
Author(s): McElhiney Linda F
Jan/Feb 2003
Pg. 10-15
View Sample
Compounding for the Effects of Weapons of Mass Destruction
Author(s): Sammarco Domenic A
Mar/Apr 2008
Pg. 153
Erythromycin 1% and Neomycin Sulfate Ointment
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 228
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Author(s): Allen Loyd V Jr
Jan/Feb 2015
Pg. 64
Erythromycin 50-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2016
Pg. 51
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Author(s): Allen Loyd V Jr
May/Jun 2001
Pg. 212
Tetracycline HCl 1% Ophthalmic Ointment
Author(s): Allen Loyd V Jr
Nov/Dec 2002
Pg. 452
Erythromycin and Dexamethasone Ophthalmic Solution
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 215
Dexamethasone Phosphate 0.05% Ophthalmic Ointment
Author(s): Allen Loyd V Jr
Nov/Dec 2003
Pg. 467
Bacitracin 500-U/g Ophthalmic Ointment
Author(s): Allen Loyd V Jr
Sep/Oct 2010
Pg. 421
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Mar/Apr 2001
Pg. 145-146
Ointment Vehicles, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 1998
Pg. 230
Glucose 40% Ophthalmic Ointment
Author(s): Allen Loyd V Jr
Sep/Oct 2003
Pg. 373
Chloramphenicol 1% Topical Ointment
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Author(s): Allen Loyd V Jr
Jan/Feb 2025
Pg. 51
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s):
Jul/Aug 2021
Pg. 344-351
Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases
Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U